PCR-DIRECTED GENE SYNTHESIS FROM LARGE NUMBER OF OVERLAPPING OLIGODEOXYRIBONUCLEOTIDES

• US 20080182296A1
• Filed: 01/31/2008
• Published: 07/31/2008
• Est. Priority Date: 01/31/2007
• Status: Abandoned Application

• Current Assignee: Wyeth (Pfizer Inc.)
• Original Assignee: Wyeth (Pfizer Inc.)
• Inventors: Nieuwenhuijsen, Bart W., Chanda, Pranab K.
• Application Number:
  US12/023,756
• Publication Number:
  US 20080182296A1
• Time in Patent Office: Days
• US Class Current: 435/69.1
• CPC Class Codes: C12N 15/1034 Isolating an individual clone by screening libraries
• CPC Class Codes: C12N 15/66 General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]

Abstract

The present invention provides methods of PCR-directed gene synthesis that may be used for all genes, including those with a high G+C content and/or a long sequence. The invention relates to methods of gene synthesis using overlapping oligonucleotides and polymerase chain reaction (PCR), wherein several PCR parameters, e.g., the concentration of overlapping oligonucleotides, the type of DNA polymerase used, and the number of PCR amplification cycles, are optimized. Additionally, the invention relates to oligonucleotide design that allows for increased protein expression of synthesized genes.

Claims

1. A PCR-directed method of synthesizing a gene of interest, wherein the method comprises the following steps:

(a) determining an optimal concentration of a plurality of overlapping oligonucleotides;

(b) assembling the plurality of overlapping oligonucleotides at the determined optimal concentration by at least one cycle of assembly PCR to generate template DNA; and

(c) amplifying the template DNA with two separate and distinct outermost overlapping oligonucleotides by at least one cycle of amplification PCR.

2. The method of claim 1, wherein the at least one cycle of assembly PCR is about 5 to about 20 cycles, and wherein the at least one cycle of amplification PCR is about 10 to about 20 cycles.

3. The method of claim 1, wherein at least one of the steps of assembling the plurality of overlapping oligonucleotides and amplifying the template DNA further comprises the steps of selecting a DNA polymerase and using the selected DNA polymerase, and wherein the DNA polymerase has a 3′

to 5′

proofreading activity.

4. The method of claim 2, wherein at least one of the steps of assembling the plurality of overlapping oligonucleotides and amplifying the template DNA further comprises the steps of selecting a DNA polymerase and using the selected DNA polymerase, and wherein the DNA polymerase has a 3′

to 5′

proofreading activity.

5. The method of claim 1, wherein the optimal concentration of the plurality of overlapping oligonucleotides is in the range of about 0.8 to about 4.0 μ

M.

6. The method of claim 3, wherein the selected DNA polymerase has an error frequency of about 0.01% or less.

7. The method of claim 1, further comprising the step of diluting the template DNA after the step of assembling the plurality of overlapping oligonucleotides and prior to the step of amplifying the template DNA.

8. The method of claim 1, further comprising, as a first step, the step of optimizing the plurality of overlapping oligonucleotides.

9. The method of claim 8, wherein the step of optimizing the plurality of overlapping oligonucleotides is accomplished by defining a host in which the synthesized gene of interest will be expressed, and optimizing codons of the plurality of overlapping oligonucleotides with respect to the defined host.

10. The method of claim 8, wherein the step of optimizing the plurality of overlapping oligonucleotides comprises altering the nucleotide sequence of at least one of the plurality of overlapping oligonucleotides such that the nucleotide sequence of the template DNA differs in at least one codon from the nucleotide sequence of the gene of interest.

11. The method of claim 10, wherein the at least one codon of the template DNA is a codon with optimal frequency of usage in the defined host, and wherein the template DNA encodes a protein having an amino acid sequence identical to the amino acid sequence of the protein encoded by the gene of interest.

12. The method of claim 10, wherein the at least one codon of the template DNA introduces a mutation into the protein encoded by the gene of interest.

13. The method of claim 1, wherein the gene of interest is about 300 to about 1700 base pairs in length.

14. The method of claim 1, wherein the gene of interest is selected from the group consisting of FAAH, hDAOA, pDAO, hCatSper3, GPR55, TREM2, IGF1, USAG1, IGFBP4, and mTPH2.

15. The method of claim 3, wherein the gene of interest is selected from the group consisting of FAAH, hDAOA, pDAO, hCatSper3, GPR55, TREM2, IGF1, USAG1, IGFBP4, and mTPH2.

16. The method of claim 15, wherein the gene of interest is selected from the group consisting of FAAH and GPR55.

17. A nucleic acid molecule comprising the gene of interest synthesized according to the method of claim 1.

18. A method of producing a polypeptide, comprising the following steps:

(a) culturing a host cell comprising the gene of interest synthesized according to the method of claim 1 under conditions such that the polypeptide is expressed; and

(b) purifying the expressed polypeptide from the host cell.

19. A polypeptide produced by the method of claim 18.